MarketCap
Fulcrum Therapeutics FULC
$ 3.71
0.54%
Facebook
X
Telegram
Country |
 USA |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
63.4 M |
Market Cap[1] |
$ 235 M |
EBITDA (LTM) |
$ -83.4 M |
P/E (LTM) |
-3.262712 |
P/S (LTM) |
3.048959 |
EPS (LTM) |
-1.18 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Histogen
HSTO
|
- | 31.6 % | $ 2.12 M | Nasdaq Global Select Market | USA |
 |
Kiromic BioPharma
KRBP
|
- | 6.61 % | $ 3.08 M | Nasdaq Global Select Market | USA |
 |
Seelos Therapeutics
SEEL
|
- | -47.76 % | $ 6.27 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Bellerophon Therapeutics
BLPH
|
- | -74.18 % | $ 955 K | Nasdaq Capital Market | USA |
 |
Baudax Bio
BXRX
|
- | 0.59 % | $ 63 K | Nasdaq Capital Market | USA |
 |
Calithera Biosciences
CALA
|
- | -10.95 % | $ 876 K | Nasdaq Global Select Market | USA |
 |
ChemoCentryx
CCXI
|
- | - | $ 3.74 B | Nasdaq Global Select Market,SPB | USA |
 |
Avid Bioservices
CDMO
|
- | - | $ 789 M | Nasdaq Capital Market | USA |
 |
Zosano Pharma Corporation
ZSAN
|
- | 7.23 % | $ 2.72 M | Nasdaq Global Select Market | USA |
 |
Spectrum Pharmaceuticals
SPPI
|
- | - | $ 189 M | Nasdaq Global Select Market | USA |
 |
VBI Vaccines
VBIV
|
- | -50.87 % | $ 1.09 M | Nasdaq Capital Market | USA |
 |
CTI BioPharma Corp.
CTIC
|
- | - | $ 1.2 B | Nasdaq Capital Market | USA |
 |
Decibel Therapeutics
DBTX
|
- | - | $ 123 M | Nasdaq Global Select Market | USA |
 |
IVERIC bio
ISEE
|
- | - | $ 5.51 B | Nasdaq Global Select Market | USA |
 |
Myovant Sciences Ltd.
MYOV
|
- | -0.04 % | $ 2.62 B | NYSE | USA |
 |
Virpax Pharmaceuticals
VRPX
|
- | -45.12 % | $ 2.85 M | Nasdaq Global Select Market | USA |
 |
Metacrine
MTCR
|
- | - | $ 24.2 M | Nasdaq Global Select Market | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Molecular Templates
MTEM
|
- | -23.43 % | $ 495 K | Nasdaq Capital Market | USA |
 |
CohBar
CWBR
|
- | -15.44 % | $ 2.2 M | Nasdaq Capital Market | USA |
 |
Deciphera Pharmaceuticals
DCPH
|
- | - | $ 2.18 B | Nasdaq Global Select Market,SPB | USA |
 |
Entasis Therapeutics Holdings
ETTX
|
- | - | $ 105 M | Nasdaq Global Market | USA |
 |
Global Blood Therapeutics
GBT
|
- | - | $ 4.62 B | Nasdaq Global Select Market,SPB | USA |
 |
Idera Pharmaceuticals
IDRA
|
- | -23.04 % | $ 26.6 M | Nasdaq Global Select Market | USA |
 |
ImmunoGen
IMGN
|
- | - | $ 7.92 B | Nasdaq Global Select Market | USA |
 |
Infinity Pharmaceuticals
INFI
|
- | -46.98 % | $ 3.57 M | Nasdaq Global Select Market | USA |
 |
Novan
NOVN
|
- | -24.84 % | $ 2.64 M | Nasdaq Capital Market | USA |
 |
NanoString Technologies
NSTG
|
- | -37.43 % | $ 5.1 M | Nasdaq Global Select Market | USA |
 |
BioDelivery Sciences International
BDSI
|
- | -4.8 % | $ 255 M | Nasdaq Global Select Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Aptinyx
APTX
|
- | -39.0 % | $ 4.57 M | Nasdaq Global Select Market | USA |
 |
AVEO Pharmaceuticals
AVEO
|
- | - | $ 521 M | Nasdaq Capital Market | USA |
 |
Inozyme Pharma
INZY
|
- | - | $ 207 M | Nasdaq Global Select Market | USA |
 |
Sorrento Therapeutics
SRNE
|
- | -29.58 % | $ 126 M | Nasdaq Global Select Market | USA |
 |
Surface Oncology
SURF
|
- | - | $ 59.7 M | Nasdaq Global Select Market | USA |
 |
Orgenesis
ORGS
|
- | -33.86 % | $ 61.2 M | Nasdaq Capital Market | USA |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$ 12.97 | 0.78 % | $ 839 M | NYSE | USA |
 |
Inhibrx
INBX
|
$ 94.56 | 0.92 % | $ 4.46 B | Nasdaq Global Select Market | USA |
 |
RedHill Biopharma Ltd.
RDHL
|
$ 0.49 | 1.0 % | $ 6.04 B | Nasdaq Global Market |  Israel |
 |
Tiziana Life Sciences PLC
TLSA
|
$ 1.07 | 0.45 % | $ 114 M | Nasdaq Global Market |  Britain |
 |
XTL Biopharmaceuticals Ltd.
XTLB
|
$ 2.18 | 0.93 % | $ 1.47 B | Nasdaq Capital Market | Israel |
 |
Zymeworks
ZYME
|
$ 26.21 | 4.21 % | $ 1.35 B | NYSE |  Canada |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Cidara Therapeutics
CDTX
|
- | - | $ 1.41 B | Nasdaq Global Market | USA |
 |
Corner Growth Acquisition Corp.
COOL
|
- | -0.89 % | $ 114 M | Nasdaq Global Select Market | USA |
 |
Dynavax Technologies Corporation
DVAX
|
- | - | $ 2.02 B | Nasdaq Capital Market | USA |
 |
Iterum Therapeutics
ITRM
|
- | - | $ 591 K | Nasdaq Global Select Market |  Irlanda |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.